Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 1
1992 6
1993 2
1994 1
1995 1
1996 1
1997 5
1998 5
1999 5
2001 1
2002 4
2003 4
2004 3
2005 4
2006 2
2007 2
2008 2
2009 4
2010 2
2011 5
2012 3
2013 4
2014 2
2015 2
2016 1
2017 2
2018 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Contraceptives, Oral, Combined.
[No authors listed] [No authors listed] 2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000354 Free Books & Documents. Review.
Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Poindexter AN, et al. Int J Fertil Womens Med. 2003 Jul-Aug;48(4):163-72. Int J Fertil Womens Med. 2003. PMID: 13677549 Clinical Trial.
The total number of cycles of exposure for the subset was 6,054 for Ortho Tri-Cyclen LO and 3,814 for Loestrin Fe 1/20. Additional analyses evaluated switchovers from Ortho Tri-Cyclen to Ortho Tri-Cyclen LO (N = 111). …
The total number of cycles of exposure for the subset was 6,054 for Ortho Tri-Cyclen LO and 3,814 for Loestrin Fe 1/20. …
Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.
Hampton RM, Short M, Bieber E, Bouchard C, Ayotte N, Shangold G, Fisher AC, Creasy GW. Hampton RM, et al. Contraception. 2001 Jun;63(6):289-95. doi: 10.1016/s0010-7824(01)00214-1. Contraception. 2001. PMID: 11672549 Clinical Trial.
Demographics were similar between regimens. Contraceptive efficacy was comparable for Ortho Tri-Cyclen Lo and Loestrin Fe 1/20. The overall and method failure probabilities of pregnancy through 13 cycles were 1.9% and 1.5%, respectively, with Ortho …
Demographics were similar between regimens. Contraceptive efficacy was comparable for Ortho Tri-Cyclen Lo and Loestrin …
Minocycline-induced renal polyarteritis nodosa.
Tabriziani H, Wilcox CS, Gilbert ON, Lipkowitz MS. Tabriziani H, et al. BMJ Case Rep. 2012 Aug 13;2012:bcr2012006503. doi: 10.1136/bcr-2012-006503. BMJ Case Rep. 2012. PMID: 22891025 Free PMC article.
This is a case report of a 21-year-old woman presented to her primary care physician with several months of fatigue, mylagias, weight loss and intermittent severe bi-temporal headaches without changes in vision. Her medications included an Ortho-Tri-Cyclen Lo …
This is a case report of a 21-year-old woman presented to her primary care physician with several months of fatigue, mylagias, weight loss a …
Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
LaGuardia KD, Shangold G, Fisher A, Friedman A, Kafrissen M. LaGuardia KD, et al. Contraception. 2003 Jun;67(6):431-7. doi: 10.1016/s0010-7824(03)00069-6. Contraception. 2003. PMID: 12814811 Clinical Trial.
Presumed ovulation (serum progesterone levels >or=3 ng/mL during Days 19-21 of Cycle 3), occurred in 0/41 (0%) subjects on ORTHO TRI-CYCLEN Lo and 3/43 (7%) subjects on ORTHO TRI-CYCLEN. Breakthrough bleeding and/or spotting (BBS; % to …
Presumed ovulation (serum progesterone levels >or=3 ng/mL during Days 19-21 of Cycle 3), occurred in 0/41 (0%) subjects on ORTHO …
The Impact of Hormonal Contraceptives on Breast Cancer Pathology.
Dorchak JA, Maria S, Guarinoni JL, Duensing A, Somiari S, Cavanaugh J, Deyarmin B, Hu H, Iida J, Shriver CD, Witt-Enderby PA. Dorchak JA, et al. Horm Cancer. 2018 Aug;9(4):240-253. doi: 10.1007/s12672-018-0332-y. Epub 2018 Apr 23. Horm Cancer. 2018. PMID: 29687205 Free PMC article.
Three combination hormonal contraceptive agents (COCs) Lo Ovral (LO), Ortho Novum (ON), and Ortho Tri-Cyclen (OTC) were evaluated as they represented the most commonly used hormonal contraceptives in our cohort. ...
Three combination hormonal contraceptive agents (COCs) Lo Ovral (LO), Ortho Novum (ON), and Ortho Tri-Cyclen (OTC) were …
Clarification of efficacy!
Friedman AJ. Friedman AJ. Fertil Steril. 2002 Oct;78(4):884-5; author reply 885. doi: 10.1016/s0015-0282(02)03315-0. Fertil Steril. 2002. PMID: 12372477 Free article. No abstract available.
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Zhang J, Chung E, Yones C, Persson A, Mahnke L, Eley T, Xu X, Bertz R. Zhang J, et al. Antivir Ther. 2011;16(2):157-64. doi: 10.3851/IMP1724. Antivir Ther. 2011. PMID: 21447864
An open-label three-period single-sequence study assessed the effect of coadministration of atazanavir (ATV)/ritonavir (RTV) with Ortho Tri-Cyclen() and with Ortho Tri-Cyclen() LO (Ortho-McNeil-Janssen Pharmaceuticals, Inc., Raritan, NJ, …
An open-label three-period single-sequence study assessed the effect of coadministration of atazanavir (ATV)/ritonavir (RTV) with Ortho …
72 results